Last updated on January 2017

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia (BPH)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Frequent Nighttime Urination (Nocturia) | Benign Prostatic Hyperplasia (Enlarged Prostate)
  • Age: 18 Years
  • Gender: Male

Nocturia for at least one year
Benign prostatic hyperplasia for at least six month under treatment

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.